Inogen Enhances Commercial Capabilities Through Partnership With Ashfield

September 24, 2021

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced a breakthrough agreement to enhance its go-to-market capabilities through a strategic partnership with Ashfield, part of UDG Healthcare. The partnership will support Inogen’s growth strategy by expanding its sales team and driving the performance of its commercial […]

Samsung Biologics showcases its newest CDO process platform, S-CellerateTM, at BPI 2021, offering expedited timeline to IND and BLA

September 22, 2021

Incheon, S. Korea, Sep 22, 2021 – Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at the BioProcess International Conference (BPI 2021) to offer clients an integrated and seamless drug development solution resulting in accelerated timelines. BPI 2021 took place both online and offline in Boston this […]

ObjectiveHealth, Formerly ObjectiveGI, Undergoes Rebrand Following Rapid Growth; Expands Into New Research Areas

September 15, 2021

ObjectiveGI Announces Name Change to ObjectiveHealth The name change to ObjectiveHealth reflects a provider-focused approach that emphasizes health and embraces care more broadly. NASHVILLE, TN, September 14, 2021 – ObjectiveGI, the integrated research and technology services platform company, announced today that they have launched a new brand identity and name change to ObjectiveHealth. The announcement […]

Quanticate Expands Leadership Team with new EVP of Business Development

September 15, 2021

(LONDON UK) – Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Nick Darbey as the company’s Executive Vice President of Business Development. Drawing on Darbey’s proven track record of growing CROs, Quanticate will leverage his business development leadership to support the growth of the business as he joins the company’s executive team. […]

Saladax Biomedical and InsightRX to Present Chemotherapy Drug Outcomes at International Congress in September

September 15, 2021

By combining an immunoassay with a cloud-based platform, clinicians are able to improve patient attainment while decreasing risks to safety and usage San Francisco—Sept. 14, 2021—InsightRX, which provides a cloud-based precision dosing platform to help guide treatment decisions, announced today that it will be participating with Saladax Biomedical, Inc., at the upcoming 19th International Congress […]

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

September 13, 2021

Incheon, S. Korea, Sept 13, 2021 – Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization, announced the signing of an MOU today to participate in the Frontier 1.5D initiative to develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the ongoing challenges associated with global […]

Create NYC Promotes Lauren Wetmore to President

August 30, 2021

Wetmore to amplify award-winning agency and support new growth opportunities. NEW YORK (August 30, 2021) – Create NYC, an award-winning healthcare marketing agency, is proud to announce the promotion of Lauren Wetmore to President. As agency lead, Wetmore will optimize relationships with existing clients, develop new business opportunities, and create customized strategic solutions. Wetmore has […]

Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

August 25, 2021

Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three years.  Quotient acquired the Alnwick facility from Arcinova in February 2021 to expand its […]

Cerba Research and ACT Genomics Announce Strategic Joint Venture — CerbACT Asia

August 24, 2021

Purpose-built facility to enable precision medicine for better patient outcomes Cerba Research, a leading global clinical trial laboratory services organization owned by Cerba HealthCare, announced today that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan covering the Asia Pacific region. This expansion of […]

Ashfield Health Appoints New Growth Director for North America

August 13, 2021

William Martino to Drive Strategy and Growth for Dynamic Network Ashfield Health, a global healthcare marketing and communications network and part of UDG Healthcare, is proud to announce and welcome William Martino as Growth Director, North America. In this new role, Martino will lead the business development for Ashfield Health and Mind+Matter, an Ashfield Health […]

Noxopharm Pre-clinical Study Confirms Survival Advantage of Combination LuPSMA Therapy in Prostate Cancer

August 12, 2021

Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) has reported pre-clinical data confirming a survival benefit of adding Veyonda® to 177lutetium-PSMA-617 (LuPSMA) treatment in prostate cancer. This result validates the survival benefit of the same combination seen in a recently completed Phase I/II trial of Veyonda in men with end-stage metastatic castrate-resistant prostate cancer (mCRPC). […]

Veranex Announces Acquisition of Experien Group

August 6, 2021

Veranex, the first concept-to-commercialization global service provider dedicated to the medtech industry, today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical consulting services to medtech companies. Formed in partnership with global growth investor Summit Partners, Veranex provides the global medical technology industry integrated product development […]

Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

July 20, 2021

Incheon, S. Korea and Seattle, WA, July 20th, 2021 – Samsung Biologics (KRX: 207940.KS), one of the world’s leading contract development and manufacturing organization (CDMO), signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical drug substance, […]

BioIVT Opens New, Larger UK Blood Donor Center on Imperial College London’s White City Campus

July 13, 2021

BioIVT’s new blood donor center is located in White City, a biotech hub, together with cell therapy, gene therapy, and pharmaceutical companies BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has moved its London, UK blood donor center from Park Royal to Scale Space White […]

Anju Software Sets New Standard for Reducing Clinical Study Build Times with TrialMaster 5.1

June 28, 2021

Release Offers New Proprietary Technology Enabling Reuse of Edit Checks Across Multiple Clinical Trials June 23, 2021 08:00 AM Eastern Daylight Time TEMPE, Ariz.–(BUSINESS WIRE)–Addressing some of the most time-consuming challenges of biopharma companies in building clinical studies and rolling out drug trials, Anju Software has launched TrialMaster 5.1, a software platform with a range […]

Genezen breaks ground on cGMP lentiviral vector production facility

June 24, 2021

Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master plan for a 75,000+ square foot cGMP-compliant Lentiviral vector production facility. The first phase will see the construction of a 25,000 square […]

AMRI Celebrates 30th Anniversary

June 22, 2021

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, celebrates 30 years since its incorporation in Albany, New York. AMRI was founded by Thomas E. D’Ambra, Ph.D., who prepared the company’s first custom synthesis from an undergraduate organic chemistry laboratory at Siena College that was rented during […]

Avania Acquires IMARC, Global Medical Device CRO

June 22, 2021

Transaction Fuels Rapid Global Expansion and Growth Avania, a leading global medical technology CRO, today announced its acquisition of IMARC, a highly respected medical device CRO headquartered in Strongsville, Ohio and providing service throughout the United States. IMARC brings more than two decades of full-service clinical research oversight to its clients, including monitoring, auditing, safety, […]

Quanticate Launches Updated Remote Source Data Verification (RSDV) Platform

June 17, 2021

LONDON (UK) – Quanticate, a leading global data-focused clinical research organisation (CRO), has launched a new Remote Source Data Verification (RSDV) Platform. The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely by a specialist team at a centralized location. Quanticate built the platform […]

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

June 16, 2021

Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to the medtech industry. Formed in partnership with global growth investor Summit Partners, the Veranex platform is designed to provide the global medical technology industry with access to real-time integrated strategy across the product life cycle. As the first phase in building […]

WCG IRB Welcomes 2021 Class to International Fellows Program on Research Ethics

June 1, 2021

Annual Program Builds on WCG IRB’s Expertise and 50-Year Legacy of Global Service, Protecting Safety of Clinical Trial Participants, Preserving Scientific Integrity of Research Protocols 2021 Program Offers Virtual Training Globally, Continuing Efforts to Improve IRB Operations Worldwide and Educate Next Generation of Research Leaders Amid COVID-19 Pandemic WCG IRB, the gold-standard Institutional Review Board […]

Ashfield Engage acquires Nuvera to enhance Patient Solutions offering

May 28, 2021

Ashfield Engage, part of UDG Healthcare plc., announces the acquisition of Nuvera LLC, a US-based healthcare consulting firm specializing in patient support programs has complete. Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment experiences. This expertise will enhance Ashfield Engage’s Patient Solutions capabilities and create an end-to-end strategic […]